Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Guangzhou
Clinical trial register · China

Clinical Trials in Guangzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Guangzhou 39 Shanghai 34 Beijing 25 Chengdu 12 Hangzhou 11
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Second Affiliated Hospital of Guangzhou Medical University8 The First Affiliated Hospital of Guangzhou Medical University6 AstraZeneca4 Guangdong Provincial People's Hospital3 Zhou Chengzhi2
Site location
Guangzhou39 Shanghai34 Beijing25 Chengdu12 Hangzhou11
All 51 locations
Target enrolment
to

Trials with a site in Guangzhou

39 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
TROP2 NMR Concordance Study
NCT07624318Lung Cancer
AstraZeneca
Observational
3,400
Beijing, Guangzhou, Shanghai
2026-08-13
Recruiting
AstraZeneca
Observational
2,000
Beijing, Chengdu, Fuzhou, Guangzhou, Nanchang, Shanghai, Shenyang, Shijiazhuang
2026-06-22
Recruiting
Hansoh BioMedical R&D Company
Phase 1
396
Guangzhou
2026-06-15
Recruiting
AstraZeneca
Phase 2
60
Beijing, Changchun, Changsha, Chengdu, Foshan, Fuzhou, Guangzhou, Harbin
2026-04-01
Recruiting
Guangzhou Concord Cancer Center
Not applicable
65
Guangzhou
2026-02-24
Not yet open
Guangzhou Medical University
Not applicable
40
Guangzhou
2026-02-01
Recruiting
Large Language Models Assist in Tumor MDT
NCT07504367Lung Cancer, Breast Cancer, Colorectal Cancer, Stomach Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
60
Guangzhou
2026-01-01
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
200
Guangzhou
2025-11-12
Recruiting
PD-L1 Inhibitor Rechallenge After Immunotherapy-Related Pneumonitis in Patients With Lung Cancer
NCT07775820Lung Cancer, Rechallenge, Checkpoint Inhibitor Pneumonitis
Nanfang Hospital, Southern Medical University
Observational
150
Guangzhou, Shenzhen, Nanchang, Wenzhou
2025-10-20
Active, closed
Feasibility of Multi-cancer Early Detection Test in Screening Population (NQMD-CS)
NCT07834268Colorectal Cancer, Grastic Cancer, Esophageal Cancer, Lung Cancer
Fifth Affiliated Hospital of Guangzhou Medical University
Not applicable
1,250
Guangzhou, Huizhou
2025-07-02
Active, closed
Merck Sharp & Dohme LLC
Phase 3
67
Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Huizhou, Jiangmen, Liuzhou
2024-11-21
Recruiting
Zhou Chengzhi
Phase 1/2
20
Guangzhou
2024-09-01
Recruiting
Jiayuan Sun
Not applicable
110
Guangzhou, Zhengzhou, Shanghai, Chengdu, Hangzhou
2024-09-01
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
5,500
Guangzhou, Wuhan, Yangzhou, Shenyang, Chengdu, Hangzhou
2024-08-01
Recruiting
The Impact of AI Assistance on Radiologist Performance and Healthcare Costs in LDCT-Based Lung Cancer Screening
NCT06988579Lung Cancer, Artificial Intelligence (AI), Randomized Controlled Trial
The First Affiliated Hospital of Guangzhou Medical University
Not applicable
7,294
Guangzhou
2024-07-01
Recruiting
ChromX Health
Observational
10,000
Guangzhou
2024-06-30
Recruiting
Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath
NCT06518655Pulmonary Nodules, Multiple, Pulmonary Nodules, Solitary, Lung Cancer
ChromX Health
Observational
3,000
Beijing, Foshan, Guangzhou, Wuhan, Shanghai, Chengdu
2024-06-30
Recruiting
GPC3/Mesothelin-CAR-γδT Cells Against Cancers
NCT06196294Pancreas Cancer, Lung Cancer, Liver Cancer, Mesothelioma
Second Affiliated Hospital of Guangzhou Medical University
Phase 1
30
Guangzhou
2024-05-10
Active, closed
AstraZeneca
Phase 2
76
Beijing, Changsha, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Nanning
2024-04-21
Recruiting
Second Affiliated Hospital of Guangzhou Medical University
Phase 2
90
Guangzhou
2024-04-04
Recruiting
The First Affiliated Hospital of Guangzhou Medical University
Phase 2
51
Guangzhou
2024-04-01
Recruiting
Interventional Software for Multi-immunotherapy of Solid Tumors
NCT06478108Lung Cancer, Liver Cancer, Solid Tumor, Adult
Second Affiliated Hospital of Guangzhou Medical University
Phase 2/3
60
Guangzhou
2024-04-01
Recruiting
The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis
NCT06244264Spinal Metastases, Blood Transfusion Complication, Lung Cancer, Surgery
Guangdong Provincial People's Hospital
Not applicable
118
Guangzhou
2024-03-15
Recruiting
Zhou Chengzhi
Phase 3
180
Guangzhou
2024-03-01
Recruiting
Guangdong Provincial People's Hospital
Not applicable
100
Guangzhou
2024-01-23
Recruiting
The First Affiliated Hospital of Guangzhou Medical University
Observational
2,500
Guangzhou
2024-01-01
Recruiting
The First Affiliated Hospital of Guangzhou Medical University
Not applicable
20
Guangzhou
2023-09-15
Active, closed
Qilu Pharmaceutical Co., Ltd.
Phase 3
606
Guangzhou
2023-02-15
Active, closed
Guangdong Association of Clinical Trials
Phase 3
192
Guangzhou
2022-06-20
Recruiting
Sun Yat-sen University
Observational
500
Guangzhou
2022-06-01
Recruiting
Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
NCT05187338Lung Cancer, Liver Cancer, Colorectal Cancer, Pancreas Cancer
DrugsIpilimumab·Durvalumab·Pembrolizumab
Second Affiliated Hospital of Guangzhou Medical University
Phase 1/2
100
Guangzhou
2021-11-01
Recruiting
Guangdong Provincial People's Hospital
Observational
300
Guangzhou
2021-09-01
Recruiting
Second Affiliated Hospital of Guangzhou Medical University
Phase 1
50
Guangzhou
2021-03-01
Recruiting
Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors
NCT04842812Liver Cancer, Lung Cancer, Breast Cancer, Colo-rectal Cancer
Second Affiliated Hospital of Guangzhou Medical University
Phase 1
40
Guangzhou
2021-01-01
Recruiting
LcProt: Proteomics Longitudinal Cohort Study on Lung Cancer
NCT06778512Lung, Lung Cancer, Cancer, NSCLC
The First Affiliated Hospital of Guangzhou Medical University
Observational
2,500
Guangzhou
2019-06-01
Recruiting
Guangdong Association of Clinical Trials
Observational
100
Guangzhou
2019-05-01
Recruiting
iCAGES-guided Precision Therapy for Cancers in Contrast to Standard Care or IHC-guided Theray
NCT03192501Lung Cancer, Gene Abnormality, Gene Product Sequence Variation, Cancer
Second Affiliated Hospital of Guangzhou Medical University
Observational
250
Guangzhou
2017-07-01
Recruiting
Second Affiliated Hospital of Guangzhou Medical University
Phase 1
30
Guangzhou
2017-07-01
Recruiting
The First Affiliated Hospital of Guangzhou Medical University
Not applicable
11,000
Guangzhou
2015-12-12
Rows per page Showing 1–39 of 39
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 November 2026. https://priyalifescience.com/clinical-trials-china/city/guangzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 08 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 39 of those studies with a site in Guangzhou that also match the filters currently applied.

How many clinical trials are recruiting in Guangzhou?

33 of the 39 studies on this page are recruiting new participants as of the 08 Nov 2026, 03:17 UTC sync. A further 1 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Guangzhou), 39 studies
PhaseStudiesRecruitingShare
Observational121230.8%
Not applicable10825.6%
Phase 15512.8%
Phase 25412.8%
Phase 34110.3%
Phase 1/2225.1%
Phase 2/3112.6%

Most active sponsors

Lead sponsors with the most studies (Guangzhou)
Lead sponsorStudiesRecruiting
Second Affiliated Hospital of Guangzhou Medical University88
The First Affiliated Hospital of Guangzhou Medical University66
AstraZeneca43
Guangdong Provincial People's Hospital33
ChromX Health22
Guangdong Association of Clinical Trials21
Zhou Chengzhi22
Fifth Affiliated Hospital of Guangzhou Medical University10
Guangzhou Concord Cancer Center11
Guangzhou Medical University10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.